- Combined therapy makes headway for liver cancer🔍
- Combination therapy for advanced hepatocellular carcinoma🔍
- Medical Xpress on X🔍
- Improving the conversion success rate of hepatocellular carcinoma🔍
- Promising Anticancer Gene Therapy Makes Headway🔍
- Drug Combination Gets Advanced Liver Cancer Patients to Surgery🔍
- Immunotherapy for recurrent hepatocellular carcinoma🔍
- HCC|TAG Conference to Highlight Headway Made in ...🔍
Combined therapy makes headway for liver cancer
Combined therapy makes headway for liver cancer
A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving ...
Combined therapy makes headway for liver cancer - Medical Xpress
A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving ...
5 likes, 0 comments - bluefaeryliver on June 6, 2024: "Combined Therapy Makes Headway For Liver Cancer A drug that targets a protein known ...
Combination therapy for advanced hepatocellular carcinoma: do we ...
Combination therapies of anti-PD-1 and anti-angiogenesis regimens are emerging rapidly and exhibit more promising anti-tumor efficacy for advanced ...
Medical Xpress on X: "#CombinedTherapy makes headway for liver ...
#CombinedTherapy makes headway for liver #cancer · @UTSWNews · @NatureComms · Combined therapy makes headway for liver cancer. From ...
Improving the conversion success rate of hepatocellular carcinoma
Conversion therapy aims to transform unresectable HCC into resectable lesions, enabling complete tumor removal. Identifying the right candidates ...
Promising Anticancer Gene Therapy Makes Headway | Charles River
Recent announcements by gene therapy CDMO client, Rznomics, underscore the potential clinical impact of a pioneering RNA-based therapeutic ...
... Research Program of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern. « Combined therapy makes headway for liver cancer.
Drug Combination Gets Advanced Liver Cancer Patients to Surgery
Combination therapy could make curative surgery possible for some liver cancer patients who would normally not be considered for the ...
Immunotherapy for recurrent hepatocellular carcinoma - PMC
The rate of recurrence was found to be 16% with liver transplantations for HCC, which is the lowest among all local therapy approaches. Thus, for patients ...
HCC-TAG Conference to Highlight Headway Made in ... - OncLive
The landscape is moving [toward] combination therapies and sequential treatment. As more first-line therapies get approved, [we need to consider] ...
New Therapies to Improve Outcomes for Patients With Intrahepatic ...
For the longest time, we had treatment with gemcitabine and cisplatin as our standard of care, a standard dual combination chemotherapy regimen.
Targeting the mTOR regulatory network in hepatocellular carcinoma
This review summarizes recent advances of the mTOR pathway, highlights the potential of the mTOR pathway as a therapeutic target, and explores clinical trials ...
Rznomics Inc. on LinkedIn: Promising Anticancer Gene Therapy ...
Promising Anticancer Gene Therapy Makes Headway Promising Anticancer Gene Therapy Makes Headway FDA designations underscore the potential ...
Cancer immunotherapy making headway - Nature
Another approach is adoptive cell therapy, which involves the use of immune cells that are re-engineered to better recognize cancer cells and ...
Pre-Op Immunotherapy Combo Makes Headway in Select Gastric ...
— Plus, novel bispecific antibody tested as first-line therapy for advanced gastric/GEJ cancer ... This article is a collaboration between MedPage ...
One new project is studying and harnessing the immune system to fight head and neck cancer, along with standard treatments. Because only one new treatment ( ...
Combination therapy might improve outcomes in treatment-resistant ...
Findings from the MGH study are directly informing ongoing clinical trials of regorafenib in cancer patients. Indeed, this work is highly ...
Angio's NanoKnife Makes Headway - Yahoo Finance
AngioDynamic's NanoKnife System delivered positive results in a clinical study for treating liver tumors located near blood vessels.
Targeting the PI3K pathway in cancer: Are we making headway?
Finally, as demonstrated in patients with metastatic hormone-receptor-positive breast cancer, combination strategies might open viable paths to ...